ReNeuron’s stem cell therapy wins orphan status – PharmaTimes
|
ReNeuron’s stem cell therapy wins orphan status
PharmaTimes Both the European Commission and US Food and Drug Administration have classed ReN003 an orphan drug for the treatment of retinitis pigmentosa, a group of hereditary progressive eye diseases that damage retinal cells and cause sight loss, which affect … |
